Patients Reported Outcomes

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Rein Therapeutics
1 program
Impact of the Routine Collection of Symptoms on Quality of Life in Dialysis PatientsN/A1 trial
Active Trials
NCT05154708TerminatedEst. Feb 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Rein TherapeuticsImpact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients

Clinical Trials (1)

NCT05154708Rein TherapeuticsImpact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients

Impact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients

Start: Jan 2022Est. completion: Feb 2024
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space